Publications

This Q&A answers some common questions about patents and international trade agreements. The rules on drug patents in international trade agreements and domestic laws affect the availability and affordability of medicines. This document explains the connection between patent issues and access to affordable drugs, to help inform advocates for the health of people in developing … Read more

This report is intended to complement and build on prior documents produced by the Canadian HIV/AIDS Legal Network related to human rights and HIV vaccine development. The report is part of a larger project led by the Canadian HIV/AIDS Legal Network to facilitate dialogue among researchers, funders, affected communities, national governments and the international community … Read more

“Thank you for your acknowledgement on 9 January 2003 of the joint and detailed letter on Access to Affordable Medicines and the WTO of 17 December 2002, sent by ICAD and twenty-six nongovernmental and civil society organizations, along with six individuals. “We appreciate your acknowledgement of our letter, but regret that you have not provided … Read more

“The purpose of this submission is three-fold. First, the Network would like to express its support for the complaint lodged on 19 September 2002 by Hazel Tau and ten others… “Second, the Network would like to place before the Commission the recent judgment of the Supreme Court of Canada in Apotex Inc. v. Wellcome Foundation … Read more

“As Canadian members of civil society, the undersigned join in expressing to you our very deep concern about the Canadian government’s position at the World Trade Organization in current negotiations on the issue of access to affordable medicines in developing countries. We have a number of specific concerns outlined below…”

In a report released on 20 November 2002, entitled Action on HIV/AIDS in Prisons: Too Little, Too Late – A Report Card, the Canadian HIV/AIDS Legal Network concluded that despite repeated studies and nearly ten years of recommendations for urgent and pragmatic action, the response of Canadian governments to HIV/AIDS, HCV, and injection drug use … Read more

On 17 May 2001, the House of Commons created a Special Committee on Non-Medical Use of Drugs based on a motion introduced by Randy White, Canadian Alliance MP (Langley–Abbottsford) and gave it a very broad mandate to study “the factors underlying or relating to the nonmedical use of drugs in Canada” and to propose recommendations … Read more

FEATURES The 1st Annual Awards for Action on HIV/AIDS and Human Rights House of Commons Committee Releases Report on Canada’s Drug Strategy HIV/AIDS in Prisons: Recent Developments CANADIAN NEWS Canada Refuses to Issue a Visa to an HIV-Positive Worker on Antiretroviral Drugs Supervised Injection Sites: Minister of Health Ready to Review Applications for Pilot Research … Read more

In 2002, over five years after the release of the “HIV/AIDS in Prisons: Final Report” (see Related Publications, below) and 10 years after Correctional Service Canada created the Expert Committee on AIDS and Prisons, it is time to assess whether the call for action made in the Final Report has been heard, and to document … Read more

In 2002, over five years after the release of the “HIV/AIDS in Prisons: Final Report” (see Related Publications, below) and 10 years after Correctional Service Canada created the Expert Committee on AIDS and Prisons, it is time to assess whether the call for action made in the Final Report has been heard, and to document … Read more